Targeted antiestrogens to prevent breast cancerJORDAN, V. C.Trends in endocrinology and metabolism. 1999, Vol 10, Num 8, pp 312-317, issn 1043-2760Article

Studies on the estrogen receptor in breast cancer : 20 years as a target for the treatment and prevention of cancerJORDAN, V. C.Breast cancer research and treatment. 1995, Vol 36, Num 3, pp 267-285, issn 0167-6806Article

Overview from the international conference on long-term tamoxifen therapy for breast cancerJORDAN, V. C.Journal of the National Cancer Institute. 1992, Vol 84, Num 4, pp 231-234, issn 0027-8874Article

Long-term adjuvant tamoxifen therapy for breast cancerJORDAN, V. C.Breast cancer research and treatment. 1990, Vol 15, Num 3, pp 125-136, issn 0167-6806Conference Paper

The development of tamoxifen for breast cancer therapy: a tribute to the late Arthur L. WalpaleJORDAN, V. C.Breast cancer research and treatment. 1988, Vol 11, Num 3, pp 197-209, issn 0167-6806Article

A current view of tamoxifen for the treatment and prevention of breast cancerJORDAN, V. C.British journal of pharmacology. 1993, Vol 110, Num 2, pp 507-517, issn 0007-1188Article

Estrogen receptor-mediated direct and indirect antitumor effects of tamoxifenJORDAN, V. C.Journal of the National Cancer Institute. 1990, Vol 82, Num 21, pp 1662-1663, issn 0027-8874Article

Are we giving tamoxifen for too long ?JORDAN, V. C.European journal of cancer : (1990). 1991, Vol 27, Num 9, pp 1070-1072Article

Laboratory evidence to support the use of long-term adjuvant tamoxifen therapy for breast cancerJORDAN, V. C.Hormone research. 1989, Vol 32, Num S1, pp 261-265, issn 0301-0163, 5 p.Conference Paper

Seminars from the university of Minnesota : Estrogen receptor as a target for the prevention of breast cancerJORDAN, V. C.The Journal of laboratory and clinical medicine. 1999, Vol 133, Num 5, pp 408-414, issn 0022-2143Article

Molecular mechanisms of antiestrogen action in breast cancerJORDAN, V. C.Breast cancer research and treatment. 1994, Vol 31, Num 1, pp 41-52, issn 0167-6806Article

Antiestrogenic action of raloxifene and tamoxifen : Today and tomorrowJORDAN, V. C.Journal of the National Cancer Institute. 1998, Vol 90, Num 13, pp 967-971, issn 0027-8874Article

What if tamoxifen (ICI 46,474) had been found to produce rat liver tumors in 1973 ? A personal perpectiveJORDAN, V. C.Annals of oncology. 1995, Vol 6, Num 1, pp 29-34, issn 0923-7534Article

A therapeutic withdrawal can make a strategic advanceJORDAN, V. C.Annals of oncology. 1992, Vol 3, Num 8, pp 587-588, issn 0923-7534Article

The control of hormone-dependent breast cancer growth: are we talking about estrogen alone?JORDAN, V. C.European journal of cancer & clinical oncology. 1988, Vol 24, Num 8, pp 1245-1248, issn 0277-5379, 4 p.Article

Laboratory models of breast cancer to aid the elucidation of antiestrogen actionJORDAN, V. C.The Journal of laboratory and clinical medicine. 1987, Vol 109, Num 3, pp 267-277, issn 0022-2143Article

Molecular mechanisms of resistance to tamoxifen therapy in breast cancerMORROW, M; JORDAN, V. C.Archives of surgery (Chicago, IL. 1960). 1993, Vol 128, Num 11, pp 1187-1191, issn 0004-0010Article

Meeting report : long-term antihormonal therapy for breast cancerCOSTA, A; JORDAN, V. C.European journal of cancer (1990). 1991, Vol 27, Num 11, pp 1479-1481, issn 0959-8049Article

Differential antiestrogen action in the immature rat uterus: a comparison of hydroxylated antiestrogens with high affinity for the estrogen receptorJORDAN, V. C; GOSDEN, B.Journal of steroid biochemistry. 1983, Vol 19, Num 3, pp 1249-1258, issn 0022-4731Article

What do we know and what don't we know about tamoxifen in the human uterusFRIEDL, A; JORDAN, V. C.Breast cancer research and treatment. 1994, Vol 31, Num 1, pp 27-39, issn 0167-6806Article

Regulation of prolactin synthesis in vitro by estrogenic and antiestrogenic derivatives of estradiol and estroneJORDAN, V. C; KOCH, R.Endocrinology (Philadelphia). 1989, Vol 124, Num 4, pp 1717-1726, issn 0013-7227Article

Should clinicians be concerned about the carcinogenic potential of tamoxifen ?JORDAN, V. C; MORROW, M.European journal of cancer. Part A. 1994, Vol 30, Num 11, pp 1714-1721Article

Oestradiol stimulates growth of oestrogen receptor-negtive MDA-MB-231 breast cancer cells in immunodeficient mice by reducing cell lossFRIEDL, A; JORDAN, V. C.European journal of cancer. Part A. 1994, Vol 30, Num 10, pp 1559-1564Article

An appraisal of strategies to reduce the incidence of breast cancerJORDAN, V. C; MORROW, M.Stem cells (Dayton, OH). 1993, Vol 11, Num 4, pp 252-262, issn 1066-5099Article

The biological action of cDNAs from mutated estrogen receptors transfected into breast cancer cellsCATHERINO, W. H; JORDAN, V. C.Cancer letters. 1995, Vol 90, Num 1, pp 35-42, issn 0304-3835Conference Paper